China Health Medical Big Data Industry Innovation Competition Launched to Accelerate Ecosystem Development

In 2015, big data was officially elevated to a national strategy, and accelerating the construction of a data powerhouse became a consensus at the national level. Among various sectors, the medical big data industry, with its still-lagging infrastructure, ushered in its best opportunity for development.

Meanwhile, a profound transformation is unfolding in China’s healthcare industry, as policy, capital, and technology unleash fierce competitive pressures, propelling medical innovation into its most turbulent and dynamic era.

In the specific domain of big data in health and healthcare, persistent challenges such as low standardization, fragmented management, and technological silos continue to prevail. These information islands severely constrain the development of the medical industry. Seeking innovative solutions in the field of medical big data has become the prime opportunity for practitioners daring to break through technical barriers to seize the opportunities presented by this era of profound healthcare transformation.

Big data applications can be integrated throughout the entire healthcare process, including drug research and development, clinical diagnosis and treatment, insurance payment and commercial insurance design, as well as health management and public health services.

The “Guiding Opinions of the General Office of the State Council on Promoting and Standardizing the Application and Development of Health and Medical Big Data” (Document No. 47), issued in June 2016, clarified that “health and medical big data is an important foundational strategic resource for the country, and its application and development will bring about profound changes to health and medical models.” This document set the tone for the development of health and medical big data. With the further advancement of the “Healthy China 2030” Plan, health and medical big data has indeed become a vital foundational strategic resource for the nation.

To implement the spirit of the CPC Central Committee’s directive on “promoting the application of health and medical big data,” to fulfill the requirements set forth in Document No. 47 issued by the General Office of the State Council, and to advance the development and application of national health and medical big data, three major health and medical big data groups, led by state-owned capital, were officially established in 2017 under the leadership of the National Health and Family Planning Commission. Among them, as the leading group, China Health and Medical Big Data Industry Development Group Co., Ltd. was established under the initiative of China Electronics Corporation.

As a specialized platform company under China Electronics Corporation (CEC) that provides data integration, management, and application services for key national industries and departments, CEC Data focuses on building two core capabilities: “security” and “intelligence.” Meanwhile, CEC Data has been extensively and deeply involved in national projects on health and medical big data and has joined relevant important organizations, serving as a national team member in the development of the health and medical big data industry. Its roles include acting as the entity responsible for the planning, construction, and operation of the National Pilot Project (Fuzhou) for the establishment of National Health and Medical Big Data Centers and Industrial Parks; serving as the sole implementing entity for the National Development and Reform Commission’s key “Internet + Healthcare” project; co-establishing the National Engineering Laboratory for Applied Technologies in Medical Big Data; and holding the position of Secretary-General Unit of the Professional Committee on Industry Development and Information Security under the Chinese Society for Health Informatics and Medical Big Data (also known as the China Health and Medical Big Data Industry Alliance).

To cultivate a healthy ecosystem for the medical and healthcare industry, CEC Health Fund, under China Electronics Data, has joined forces with Medlinker, SPDB Silicon Valley Bank, Tasly Capital, Lingyi Center, Zhongguancun Technology Leasing, VCBeat, and other institutions to jointly launch the China Health and Medical Big Data Industry Innovation Competition.

The China Health and Medical Big Data Industry Innovation Competition is guided by the Industrial Development and Information Security Professional Committee of the Chinese Society for Health Informatics and Medical Big Data (China Health and Medical Big Data Industry Alliance), hosted by CEC Data Service Co., Ltd. and CEC Shurong Investment Management Co., Ltd., co-hosted by Medlinker, and co-organized by Shanghai Pudong Development Bank Silicon Valley Bank, Lingyi Center, Tasly Capital, and Zhongguancun Technology Leasing, with VCBeat as the organizer. As China’s first innovation competition focused on enterprises centered around the health and medical big data industry, it aims to discover, nurture, and select high-quality projects, accelerating the construction of a business ecosystem, data ecosystem, and capital ecosystem anchored by national-level teams in the health and medical sector.

The ALL IN-China Health and Medical Big Data Industry Innovation Competition features the following highlights:

Covers all sub-sectors of China's healthcare big data industry ecosystem;

Focusing on the most innovative medical services, data technology, and data security projects across the entire industry;

Bringing together the most authoritative technical experts, investment experts, and industry research experts from across the entire sector;

Enable China’s leading innovative healthcare enterprises to understand the most cutting-edge trends in industrial investment;

Facilitating dialogue between China’s leading innovative healthcare enterprises and its top-tier investment experts;

Join hands with the national team to partner with China’s leading big data healthcare enterprises;

Empower China’s most outstanding innovative healthcare enterprises to soar, grant time to the diligent, enable the persistent to create a better future, steer the healthcare industry back to its true value, and jointly advance the development of China’s healthcare sector.

For a long time, the development of the medical big data industry has been hindered by numerous challenges, such as the integration of data interoperability, data-sharing mechanisms, and data security and privacy. With strong national policy guidance driving the growth of the health and medical industry, leveraging state power in conjunction with industrial capital will effectively address these issues.

In the process of building its industrial ecosystem, China Electronics Data also established the CE Health Fund to create a platform and aggregate data, flexibly pooling and mobilizing resources through investment. In June 2017, China Electronics Data initiated the establishment of the CE Health Medical Big Data (Hangzhou) Equity Investment Fund Partnership (Limited Partnership) and its management company—CE Digital Finance Investment Management (Hangzhou) Co., Ltd., with a fund management scale of RMB 3 billion.

As a key capital link in CEC Data’s ecosystem strategy, the fund focuses on investing in highly relevant sectors radiating from the health and medical data industry, including Fintech, Biotech, artificial intelligence, and next-generation internet technologies.

CEC Health Fund has formulated a “1+1+X” investment strategy. First, the enterprise should be a leader in a single niche within the healthcare sector, with its closed-loop business model beginning to take shape; this constitutes the first “1.” Second, CEC Health Fund will help the enterprise introduce industrial and policy resources to achieve horizontal expansion across sectors, representing the second “1.” Finally, the fund will bring in data resources to collaborate with the enterprise on industrial upgrading, achieving business sharing, benefit sharing, and ecosystem synergy, which is symbolized by “X.”

Therefore, this competition will be open to applicants across China, with seven regional divisions established in Beijing, Hangzhou, Shenzhen, Chengdu, Fuzhou, Wuhan, and Guangzhou. The contest comprises three stages: preliminary rounds, regional finals, and the national grand final. It features three categories in the healthcare sector—“Angel Star,” “Growth Star,” and “Future Star”—as well as a “Basic Data” category in the TMT sector, ultimately selecting high-quality projects from across the country.

Covering 20+ niche sectors in the health and medical big data industry, with a network of 20+ healthcare service institutions at various levels across China, we provide participating enterprises with opportunities for business implementation. Additionally, over 300 top-tier investment institutions nationwide offer resource-matching opportunities, while more than 150 industry experts deliver “many-to-one” project consulting and mentoring services.

(1) All teams advancing to the National Finals are eligible for direct business collaboration and resource alignment with the organizer.

Ecological Empowerment:Leveraging its advantages as a state-backed enterprise, China Electronics Data provides guidance and support to teams advancing to the finals in areas such as policy orientation, strategic decision-making, and ecosystem resources.

Capital Empowerment:Leveraging the advantages of CEC Data’s national team in healthcare big data, CEC Health Fund collaborates with Medlinker, China’s leading real-name physician platform; Pudong Development Bank Silicon Valley Bank; and Zhongguancun Science & Technology Leasing, a leading financial leasing company in China. Using capital as a strategic lever, the fund provides direct support, incubation, venture capital investment, and loan services to teams that have advanced to the national finals.

Technology and Data Empowerment:CEC Data will provide support and guidance to teams advancing to the national finals in areas such as connectivity, computing power, and data. SPDB Silicon Valley Bank offers resource collaboration opportunities in innovative fields including hardware, software, internet, life sciences, and biotechnology.

(II) Teams advancing to the national finals will compete for awards including Best Business Model Award, Most Collaborative Value Award, Best Technological Innovation Award, Best Service Innovation Award, Most Valuable Brand Award, Most Investment-Worthy Award, and Best Data Technology Application Award, and will be included in the China Health and Medical Innovation Project Database.

Guiding Organizations

Professional Committee on Industrial Development and Information Security, Chinese Society for Health Informatics and Medical Big Data (China Health and Medical Big Data Industry Alliance)

Organizer

China Electronics Data Service Co., Ltd.

CEC Digital Finance Investment Management Co., Ltd.

Co-organized by

MedLink

Co-organizers

SPD Silicon Valley Bank

Tasly Capital

Lingyi Center

Zhongguancun Science and Technology Leasing

Organizer

VCBeat

Regional Division Co-Organizers

Baichuanghui

Probe Capital

Health Intelligence Valley

PKU Healthcare Innovation Valley

Wuhan Optics Valley Smart Health Park

Startupbootcamp（SBC）

Guanhao Life and Health Science Park

Supporting Organizations

Sequoia Capital, SoftBank China, Legend Capital, Puhua Capital, Huagai Medical Fund, Ping An Ventures, Boyuan Capital, Tonghe Yucheng, Qiming Venture Partners, Lenovo Star, Demo Capital, Fortune Capital, Zero2IPO Capital, Huayi Capital, Hualing Capital, Matrix Partners China, Duowei Capital, Haoyue Capital, Daotong Capital, Lianghe Venture Capital, Delian Capital, BlueRun Ventures, Fuyu Asia, Yuanjing Capital, Beijing Chunxin Capital, Shiyu Capital, Morningside Venture Capital, Cowin Capital, Volcanic Stone Capital, Buchang Pharmaceuticals (Yuan Yuan Liu Chang), Chende Capital, Vertex Ventures, Shangshi Capital, Oriental Fortune Capital, Caijin Capital, Jinpu Investment (Mobile Healthcare), Hongli Venture Capital, Anlong Fund, China Equity Group, Fukun Venture Capital, Binghong Capital, BGI Win-Win, Silver Australia Capital, Mifang Capital, Tongdu Capital, Taikang Asset Management, Yueyin Medical Fund, Shanlan Capital, Huiding Jishi, Small is Big, Langsheng Investment, Xiyu Capital, CMB International Capital, Guoke Jiahe, Qualcomm Investments, Beijing Enterprises Medical Industry Fund, Kaifeng Venture Capital, GTJA Capital, CICC Zhide, Western China Medical and Health Expo, Shell Society, Tencent众创Space, Optics Valley Biopharmaceutical Industrial Park, Zhongguancun Life Science Park, Nebula Accelerator (Wuhan), Wujie Advanced Studies, Weiyi Association, Baidu, Xiao Fan Zhuo

This competition extensively invites entrepreneurial projects from China’s health and medical sectors that feature technological innovation or business model innovation, as well as pan-data projects in the TMT sector. Technological innovation projects include, but are not limited to, those in the fields of internet, big data, artificial intelligence, data governance technologies, blockchain, Internet of Things (IoT), genetic testing, and smart devices.

Business model innovation categories include, but are not limited to, smart Traditional Chinese Medicine (TCM), TCM herbal decoction pieces, TCM aesthetics, TCM consultations, TCM nursing, TCM big data services, internet healthcare, pharmaceutical retail and distribution, primary healthcare, healthcare informatization, consumer healthcare services, maternal and child health, rehabilitation and nursing care, medical consultation and medication services, health management, health insurance, artificial intelligence, clinical tools, and innovations in various testing services.

Pan-data projects include, but are not limited to, data security technologies, cloud security technologies, algorithms, and computing power. 

(I) Preliminary Round

1. Registration Channel: Participating organizations shall register uniformly via the official competition website at http://vcbeat.top/cdhicRegistrationRegistration Period: May 11–June 25

2. Competition Review: The Organizing Committee shall review and confirm the entries; projects that pass the review will qualify for the preliminary round.

Review Period: May 12–June 26

3. Preliminary Round Evaluation: The preliminary round judging panel will score the participating projects according to the detailed scoring criteria. A secondary comprehensive review will then be conducted based on the score rankings to determine the projects advancing to the regional finals.

Review Period: May 12–June 27

Scan the QR code to register

(II) Regional Finals

The regional finals were held across seven zones in China—Beijing, Chengdu, Shenzhen, Hangzhou, Fuzhou, Wuhan, and Guangzhou—with thirty projects ultimately selected to advance to the national grand finals.

(3) National Finals

The National Finals of the China Health and Medical Big Data Industry Innovation Conference were held in Beijing, with 30 projects shortlisted for simultaneous pitch presentations. The final selections are as follows:

Angel Star Category: One Gold Award, one Silver Award, and one Bronze Award;

Rising Star Category: One Gold Award, One Silver Award, and One Bronze Award;

Rising Star Category: One Gold Award, one Silver Award, and one Bronze Award;

Basic Data Category: One Gold Award, one Silver Award, and one Bronze Award.